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Brown tumour represents a serious complication of hyperparathyroidism. Diﬀerential diagnosis, based on histological
examination, is only presumptive and clinical, radiological and laboratory data are necessary for deﬁnitive diagnosis. Here we
describe a case of a brown tumour localised in the maxilla due to secondary hyperparathyroidism in a young women with chronic
renal failure. Hemodialysis and pharmacological treatment were unsuccessful in controlling secondary hyperparathyroidism
making it necessary to proceed with a subtotal parathyroidectomy. The proper timing of the parathyroidectomy and its favourable
eﬀect on regression of the brown tumor made it possible to avoid a potentially disﬁguring surgical removal of the brown tumor.
Copyright © 2009 Nicola Di Daniele et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Secondary hyperparathyroidism is a frequent complication
ofchronicrenalfailureasaconsequenceofrenalosteodystro-
phy. Brown tumours, as unifocal or multifocal bone lesions,
represent a serious complication of advanced hyperparathy-
roidism with a frequency of 1.5–1.75 percent in secondary
hyperparathyroidism and 3–4 percent in primary hyper-
parathyroidism.
It usually aﬀects young people especially females with
varying degrees of aggressiveness and risks of recurrence [1–
3].Itcanaﬀectthebaseoftheskull,orbits,paranasalsinuses,
spinal column [4, 5] as well femur, tibia, humerus, clavicles
and scapula. However, it is relatively rare in the maxilla with
a frequency of 4.5–11.8 percent [6].
Radiologically, brown tumour in the jaws presents as a
well-deﬁned radiolucent osteolytic lesion that can encircle
the roots of teeth, making it hard to diﬀerentiate it from
other maxillary expansive lesions that can present with a
similar imaging.
Histopathological examination of brown tumours can
suggest the diagnosis but may not be suﬃcient to diﬀerenti-
ate it conclusively from other lesions which can have similar
microscopic and macroscopic features such as regenerative
granuloma [4, 7, 8], giant cell granuloma, giant cell tumour,
aneurysmatic cyst, cherubism, Paget’s disease, odontologic
bone tumour, and nonodontologic ﬁbrous dysplasia. A ﬁnal
diagnosis can be deﬁned only by evaluating the radiological
ﬁndings with histopathological, laboratory, and clinical data.
At present, brown tumour is considered as a reparative cellu-
lar process rather than a real neoplasia. This phenomenon
is considered as pathognomonic of hyperparathyroidism
secondarytorenalfailure,especiallyinpatientsonlong-term
hemodialysis [9–13].
Usually brown tumours do not present with pain unless
their dimensions are large enough to compress neighbouring2 International Journal of Endocrinology
nerve structures. They are often discovered incidentally on
routine radiological examinations. In most cases, when the
pathway of growth of the tumour is closed and its position
is not causing clinical problems, its surgical treatment is not
indicated nor necessary.
The most important complications of this neoformation
are related to its position and size and the possible eﬀects on
nearby structures. It can be a cause of an increased risk of
fracture, of spinal cord compression, or of facial disﬁgura-
tion, compromising normal functions such as mastication,
compression,phonation,andsocialeaseofthepatient.Other
neurological complications include diplopia if the optical
n e r v ei si n v o l v e d[ 5, 14].
The clinical management of a brown tumour aims pri-
marily to reduce the elevated parathyroid hormone levels by
pharmacological treatment. Surgical treatment is reserved to
nonresponders or to patients with painful symptomatology
or alteration of normal function.
2.CaseReport
In this paper, we describe a 40-years-old woman with a
local lesion of the right side of the maxilla. Her history
reveals that she was in relatively good health until the age
of 20, when she started to complain of frequent headaches
and vomiting up to three times a week. Clinical evaluation
revealed arterial hypertension and renal failure. A kidney
biopsy was not diagnostic. In February 1989, she was started
on chronic haemodialysis three times weekly. In 1991, she
receiveda kidney transplantfroma cadaveric donor. In1997,
she developed a non-Hodgkin lymphoma. Chemotherapy
for one year lead to a complete remission of the lymphoma.
In March 1999, she developed aseptic necrosis of the femoral
head which was treated surgically. In June 1999, as she devel-
oped progressive deterioration of the transplanted kidney
function, haemodialysis three times weekly was restarted.
In October 1999, the transplanted kidney was removed and
during surgery, she developed thrombosis of the left central
retinal vein. Laboratory investigations in December 2000
revealed elevated serum parathyroid hormone (PTH) level
of 282pg/mL (normal range 14–72pg/mL). At the same
time, she noted a swelling in the right side of the maxilla. A
radiograph of the maxilla showed an area of bone rarefaction
(Figure 1).
Five months later, a computed tomography and an
electronic rebuilding dental scan showed a hypodense neo-
formation with heterogeneous borders and erosions. Bone
structure was interrupted both laterally and medially on the
lingual side. A lesion with a maximum diameter of about
4cm involved the roots and peri-apical tissue of teeth 4.4,
4.5, 4.6, and part of 4.7. Two other similar lesions each about
1 cm in diameter were seen in the chin region and the right
side of the maxilla (Figure 2).
Since radiographs showed a radiographic image compat-
ible with more than one possible lesion and hence were not
suﬃcient to provide a deﬁnitive diagnosis, a biopsy of the
lesions was performed. Histological examination revealed
giant bone cells. This together with the laboratory evidence
forsecondaryhyperparathyroidism,thediagnosisofabrown
Figure1:(December12,2000)X-rayofthemaxillathathighlighted
a bony rarefaction area.
tumour was made. The patient was treated for secondary
hyperparathyroidism with vitamin D, calcium, bisphospho-
nates, phosphate binders, and reduced phosphate intake. In
July 2001, despite the above treatment, she continued to
have severe and worsening hyperparathyroidism with PTH
levels of 1700pg/mL, with serum calcium of 10.5mg/dl
(normal range 8.6–10.2mg/dl), phosphate of 5.3 mg/dl
(normal range 2.7–4.5mg/dl), and alkaline phosphatase
of 319IU/L (normal range 40–120IU/L). At the same
time, the bony lesions increased in size but with signs of
modest recalciﬁcation. In October 2001, the refractoriness
to medical therapy was evident and a parathyroidectomy
became necessary. Surgical treatment consisted of removal
of all 4 parathyroids and implantation of 1/3 of the inferior
parathyroid in the right forearm muscle. This was followed
by a dramatic fall in serum PTH levels and normalisation of
serumcalciumandphosphatelevelsresultinginregressionof
the brown tumour. February 2002, the lesions were partially
calciﬁedandinJune2003,computedtomographyanddental
scan showed a normal bone structure in the area that was
previouslyinvolvedwiththebrowntumourbutwithresidual
hyperostosis.InDecember2003,alveolarbonewasthickened
both on the external and on the medial side. Thereafter,
annual computed tomography and dental scan and monthly
blood tests were carried out, and on the last examination
in February 2007, there was thickened alveolar bone of the
right mandibular arch with a proﬁle deformity but without
a cortical gap. There was a regular morphology of the
mandibular canal without signs of inﬁltration (Figure 3).
In summary, this case shows that it is possible to
avoid surgical of a large brown tumour even though
it compromised the physical appearance of the patient
and caused dysfunction of the masticatory apparatus. The
surgical resolution of hyperparathyroidism was enough to
correct the calcium-phosphate-PTH imbalance and to result
in regression of the jaw lesions.
3. Conclusion
Brown tumour can develop very quickly as happened in
this case. Medical treatment, even if appropriate can be
insuﬃcient to control the secondary hyperparathyroidism.International Journal of Endocrinology 3
Figure 2: (May 29, 2001) TC deltascan shows the hypodense,
disomogeneus borders neoformation with erosive character.
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Figure 3: (February 08, 2007) TC deltascan reveals a thickening
of alveolar bone of the right mandibular arch with a deformity of
proﬁle without a gap of cortical and reveals the regular morphology
along the mandibular canal, without sure images referable to
inﬁltration on it.
Therefore,anearlydiagnosisandatimelyparathyroidectomy
in a medically resistant hyperparathyroidism are an optimal
option to control the growth of the bony lesion and to
avoid further weakening of bone structure and consequent
increased risk of fractures, compression of contiguous struc-
tures,deformities,andfunctionalalterationofotherinvolved
areas of the skeleton.
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